Association between the activation of MCH and orexin immunorective neurons and REM sleep architecture during REM rebound after a three day long REM deprivation. 2011

Tamas Kitka, and Csaba Adori, and Zita Katai, and Szilvia Vas, and Eszter Molnar, and Rege S Papp, and Zsuzsanna E Toth, and Gyorgy Bagdy
Department of Pharmacodynamics, Semmelweis University, Nagyvárad tér 4, H-1089 Budapest, Hungary.

Rapid eye movement (REM) sleep rebound following REM deprivation using the platform-on-water method is characterized by increased time spent in REM sleep and activation of melanin-concentrating hormone (MCH) expressing neurons. Orexinergic neurons discharge reciprocally to MCH-ergic neurons across the sleep-wake cycle. However, the relation between REM architecture and the aforementioned neuropeptides remained unclear. MCH-ergic neurons can be divided into two subpopulations regarding their cocaine- and amphetamine-regulated transcript (CART) immunoreactivity, and among them the activation of CART-immunoreactive subpopulation is higher during the REM rebound. However, the possible role of stress in this association has not been elucidated. Our aims were to analyze the relationship between the architecture of REM rebound and the activation of hypothalamic MCH-ergic and orexinergic neurons. We also intended to separate the effect of stress and REM deprivation on the subsequent activation of subpopulations of MCH-ergic neurons. In order to detect neuronal activity, we performed MCH/cFos and orexin/cFos double immunohistochemistry on home cage, sleep deprived and sleep-rebound rats using the platform-on-water method with small and large (stress control) platforms. Furthermore, REM architecture was analyzed and a triple MCH/CART/cFos immunohistochemistry was also performed on the rebound groups in the same animals. We found that the activity of MCH- and orexin-immunoreactive neurons during REM rebound was positively and negatively correlated with the number of REM bouts, respectively. A negative reciprocal correlation was also found between the activation of MCH- and orexin-immunoreactive neurons during REM rebound. Furthermore, difference between the activation of CART-immunoreactive (CART-IR) and non-CART-immunoreactive MCH-ergic neuron subpopulations was found only after selective REM deprivation, it was absent in the large platform (stress control) rebound group. These results support the role of CART-IR subpopulation of MCH-ergic neurons and the inverse relationship of MCH and orexin in the regulation of REM sleep after REM sleep deprivation.

UI MeSH Term Description Entries
D007028 Hypothalamic Hormones Peptide hormones produced by NEURONS of various regions in the HYPOTHALAMUS. They are released into the pituitary portal circulation to stimulate or inhibit PITUITARY GLAND functions. VASOPRESSIN and OXYTOCIN, though produced in the hypothalamus, are not included here for they are transported down the AXONS to the POSTERIOR LOBE OF PITUITARY before being released into the portal circulation. Hypothalamic Pituitary-Regulating Hormones,Hypothalamic Pituitary-Regulating Peptides,Hormones, Hypothalamic,Hormones, Hypothalamic Pituitary-Regulating,Hypothalamic Pituitary Regulating Hormones,Hypothalamic Pituitary Regulating Peptides,Peptides, Hypothalamic Pituitary-Regulating,Pituitary-Regulating Hormones, Hypothalamic,Pituitary-Regulating Peptides, Hypothalamic
D007031 Hypothalamus Ventral part of the DIENCEPHALON extending from the region of the OPTIC CHIASM to the caudal border of the MAMMILLARY BODIES and forming the inferior and lateral walls of the THIRD VENTRICLE. Lamina Terminalis,Preoptico-Hypothalamic Area,Area, Preoptico-Hypothalamic,Areas, Preoptico-Hypothalamic,Preoptico Hypothalamic Area,Preoptico-Hypothalamic Areas
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D008543 Melanins Insoluble polymers of TYROSINE derivatives found in and causing darkness in skin (SKIN PIGMENTATION), hair, and feathers providing protection against SUNBURN induced by SUNLIGHT. CAROTENES contribute yellow and red coloration. Allomelanins,Melanin,Phaeomelanins
D009419 Nerve Tissue Proteins Proteins, Nerve Tissue,Tissue Proteins, Nerve
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D009479 Neuropeptides Peptides released by NEURONS as intercellular messengers. Many neuropeptides are also hormones released by non-neuronal cells. Neuropeptide
D010907 Pituitary Hormones Hormones secreted by the PITUITARY GLAND including those from the anterior lobe (adenohypophysis), the posterior lobe (neurohypophysis), and the ill-defined intermediate lobe. Structurally, they include small peptides, proteins, and glycoproteins. They are under the regulation of neural signals (NEUROTRANSMITTERS) or neuroendocrine signals (HYPOTHALAMIC HORMONES) from the hypothalamus as well as feedback from their targets such as ADRENAL CORTEX HORMONES; ANDROGENS; ESTROGENS. Hormones, Pituitary
D004569 Electroencephalography Recording of electric currents developed in the brain by means of electrodes applied to the scalp, to the surface of the brain, or placed within the substance of the brain. EEG,Electroencephalogram,Electroencephalograms

Related Publications

Tamas Kitka, and Csaba Adori, and Zita Katai, and Szilvia Vas, and Eszter Molnar, and Rege S Papp, and Zsuzsanna E Toth, and Gyorgy Bagdy
January 2023, Frontiers in neuroscience,
Tamas Kitka, and Csaba Adori, and Zita Katai, and Szilvia Vas, and Eszter Molnar, and Rege S Papp, and Zsuzsanna E Toth, and Gyorgy Bagdy
May 2005, The European journal of neuroscience,
Tamas Kitka, and Csaba Adori, and Zita Katai, and Szilvia Vas, and Eszter Molnar, and Rege S Papp, and Zsuzsanna E Toth, and Gyorgy Bagdy
August 1990, Electroencephalography and clinical neurophysiology,
Tamas Kitka, and Csaba Adori, and Zita Katai, and Szilvia Vas, and Eszter Molnar, and Rege S Papp, and Zsuzsanna E Toth, and Gyorgy Bagdy
June 2019, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Tamas Kitka, and Csaba Adori, and Zita Katai, and Szilvia Vas, and Eszter Molnar, and Rege S Papp, and Zsuzsanna E Toth, and Gyorgy Bagdy
April 2006, Brain research bulletin,
Tamas Kitka, and Csaba Adori, and Zita Katai, and Szilvia Vas, and Eszter Molnar, and Rege S Papp, and Zsuzsanna E Toth, and Gyorgy Bagdy
January 2018, Frontiers in neuroscience,
Tamas Kitka, and Csaba Adori, and Zita Katai, and Szilvia Vas, and Eszter Molnar, and Rege S Papp, and Zsuzsanna E Toth, and Gyorgy Bagdy
March 2018, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Tamas Kitka, and Csaba Adori, and Zita Katai, and Szilvia Vas, and Eszter Molnar, and Rege S Papp, and Zsuzsanna E Toth, and Gyorgy Bagdy
December 2013, Sleep,
Tamas Kitka, and Csaba Adori, and Zita Katai, and Szilvia Vas, and Eszter Molnar, and Rege S Papp, and Zsuzsanna E Toth, and Gyorgy Bagdy
June 2024, Psychopharmacology,
Tamas Kitka, and Csaba Adori, and Zita Katai, and Szilvia Vas, and Eszter Molnar, and Rege S Papp, and Zsuzsanna E Toth, and Gyorgy Bagdy
August 2010, The European journal of neuroscience,
Copied contents to your clipboard!